Literature DB >> 9058178

Potential for hostility and faking-good in high-hostile men.

K Davidson1, P Hall.   

Abstract

We investigated if Type A Structured Interview (SI)-assessed hostility (PoHo) is subject to voluntary underreporting, or faking-good, by hostile subjects. Sixteen men who previously scored above the clinical cutoff of 3 on SI hostility were randomly assigned to an experimental (N = 8) or control (N = 8) group. Both groups underwent a second videotaped SI, prior to which experimental subjects were asked to present themselves in a favorable light. Repeated-measures ANOVA revealed that experimental subjects were able successfully to decrease their global PoHo scores when instructed to do so (38% scored below the clinical cutoff score). The SI-derived hostility score is vulnerable to faking-good, and attention should be paid to both the motivational set of subjects and the instructions given prior to the SI.

Entities:  

Mesh:

Year:  1997        PMID: 9058178     DOI: 10.1023/a:1025587113192

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  13 in total

1.  A PREDICTIVE STUDY OF CORONARY HEART DISEASE.

Authors:  R H ROSENMAN; M FRIEDMAN; R STRAUS; M WURM; R KOSITCHEK; W HAHN; N T WERTHESSEN
Journal:  JAMA       Date:  1964-07-06       Impact factor: 56.272

2.  Competitive drive, pattern A, and coronary heart disease: a further analysis of some data from the Western Collaborative Group Study.

Authors:  K A Matthews; D C Glass; R H Rosenman; R W Bortner
Journal:  J Chronic Dis       Date:  1977-08

3.  Hostility, coronary heart disease, and total mortality: a 33-year follow-up study of university students.

Authors:  M D Hearn; D M Murray; R V Luepker
Journal:  J Behav Med       Date:  1989-04

4.  Potential for hostility and dimensions of anger.

Authors:  L Musante; J M MacDougall; T M Dembroski; P T Costa
Journal:  Health Psychol       Date:  1989       Impact factor: 4.267

5.  Coronary prone behavior: components of the type A pattern and hostility.

Authors:  T M Dembroski; P T Costa
Journal:  J Pers       Date:  1987-06

6.  Coronary-prone behaviors in the Western Collaborative Group Study.

Authors:  M H Hecker; M A Chesney; G W Black; N Frautschi
Journal:  Psychosom Med       Date:  1988 Mar-Apr       Impact factor: 4.312

7.  Type A behavior and angiographically documented coronary atherosclerosis in a sample of 2,289 patients.

Authors:  R B Williams; J C Barefoot; T L Haney; F E Harrell; J A Blumenthal; D B Pryor; B Peterson
Journal:  Psychosom Med       Date:  1988 Mar-Apr       Impact factor: 4.312

8.  Components of hostility as predictors of sudden death and myocardial infarction in the Multiple Risk Factor Intervention Trial.

Authors:  T M Dembroski; J M MacDougall; P T Costa; G A Grandits
Journal:  Psychosom Med       Date:  1989 Sep-Oct       Impact factor: 4.312

9.  Dimensions of hostility in men, women, and boys: relationships to personality and cardiovascular responses to stress.

Authors:  T O Engebretson; K A Matthews
Journal:  Psychosom Med       Date:  1992 May-Jun       Impact factor: 4.312

10.  Hostility, coronary heart disease (CHD) incidence, and total mortality: lack of association in a 25-year follow-up study of 478 physicians.

Authors:  E W McCranie; L O Watkins; J M Brandsma; B D Sisson
Journal:  J Behav Med       Date:  1986-04
View more
  2 in total

1.  Observed hostility and the risk of incident ischemic heart disease: a prospective population study from the 1995 Canadian Nova Scotia Health Survey.

Authors:  Jonathan D Newman; Karina W Davidson; Jonathan A Shaffer; Joseph E Schwartz; William Chaplin; Susan Kirkland; Daichi Shimbo
Journal:  J Am Coll Cardiol       Date:  2011-09-13       Impact factor: 24.094

2.  Differences in health-related quality of life between Roma and non-Roma coronary heart disease patients: the role of hostility.

Authors:  Barbora Silarova; Jitse P van Dijk; Iveta Nagyova; Jaroslav Rosenberger; Sijmen A Reijneveld
Journal:  Int J Public Health       Date:  2013-07-11       Impact factor: 3.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.